Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-19 4:30 pm Purchase |
2024-03-14 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Lind Global Fund II LP | 156,250 5.700% |
156,250 (New Position) |
Filing History |
| 2024-03-06 4:24 pm Purchase |
2024-03-01 | 13G | Oragenics, Inc. OGEN |
Lind Global Fund II LP | 265,000 5.900% |
265,000 (New Position) |
Filing History |
| 2024-02-21 4:39 pm Purchase |
2024-02-15 | 13G | BIOLASE INC PAR $.001 BIOLQ |
Lind Global Fund II LP | 1,190,000 9.900% |
1,180,790 (+12820.74%) |
Filing History |
| 2024-02-21 4:38 pm Sale |
2024-02-16 | 13G | ToughBuilt Industries, Inc. TBLT |
Lind Global Fund II LP | 77,000 9.900% |
-1,145,387 (-93.70%) |
Filing History |
| 2024-02-15 7:36 pm Purchase |
2024-02-12 | 13G | Tenet Healthcare Corporation THC |
Lind Global Fund II LP | 71,500 9.900% |
71,500 (New Position) |
Filing History |
| 2024-02-13 8:16 pm Purchase |
2023-12-31 | 13G | WiSA Technologies, Inc. WISA |
Lind Global Fund II LP | 203 0.200% |
203 (New Position) |
Filing History |
| 2024-02-13 8:15 pm Sale |
2023-12-31 | 13G | Windtree Therapeutics, Inc. WINT |
Lind Global Fund II LP | 322 5.300% |
-206 (-38.94%) |
Filing History |
| 2024-02-13 8:15 pm Purchase |
2023-12-31 | 13G | Versus Systems Inc. VS |
Lind Global Fund II LP | 275,000 9.900% |
275,000 (New Position) |
Filing History |
| 2024-02-13 8:15 pm Purchase |
2023-12-31 | 13G | T2 Biosystems, Inc. TTOO |
Lind Global Fund II LP | 20,370 0.500% |
20,370 (New Position) |
Filing History |
| 2024-02-13 8:14 pm Purchase |
2023-12-31 | 13G | ToughBuilt Industries, Inc. TBLT |
Lind Global Fund II LP | 1,222,387 3.200% |
1,189,010 (+3562.35%) |
Filing History |
| 2024-02-13 8:14 pm Purchase |
2023-12-31 | 13G | Siyata Mobile Inc. SYTA |
Lind Global Fund II LP | 285 8.600% |
285 (New Position) |
Filing History |
| 2024-02-13 8:13 pm Purchase |
2023-12-31 | 13G | SenesTech, Inc. SNES |
Lind Global Fund II LP | 10,300 9.900% |
10,300 (New Position) |
Filing History |
| 2024-02-13 8:13 pm Purchase |
2023-12-31 | 13G | SMX (Security Matters) Public Limited Company SMX |
Lind Global Fund II LP | 78 4.100% |
10 (+14.55%) |
Filing History |
| 2024-02-13 8:12 pm Sale |
2023-12-31 | 13G | Sintx Technologies, Inc. SINT |
Lind Global Fund II LP | 0 0.000% |
-4,325 (Position Closed) |
Filing History |
| 2024-02-13 8:12 pm Sale |
2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
Lind Global Fund II LP | 796 0.100% |
-1,098 (-57.95%) |
Filing History |
| 2024-02-13 8:12 pm Purchase |
2023-12-31 | 13G | Revelation Biosciences, Inc. REVB |
Lind Global Fund II LP | 11,656 2.900% |
11,268 (+2900.00%) |
Filing History |
| 2024-02-13 8:11 pm Sale |
2023-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX |
Lind Global Fund II LP | 3,125 6.000% |
-1,000 (-24.24%) |
Filing History |
| 2024-02-13 8:11 pm Purchase |
2023-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 251,770 9.900% |
251,770 (New Position) |
Filing History |
| 2024-02-13 8:10 pm Sale |
2023-12-31 | 13G | Polar Power, Inc. POLA |
Lind Global Fund II LP | 3,917 0.200% |
-138,940 (-97.26%) |
Filing History |
| 2024-02-13 8:10 pm Unchanged |
2023-12-31 | 13G | Panbela Therapeutics, Inc. PBLA |
Lind Global Fund II LP | 0 0.000% |
0 (Unchanged) |
Filing History |